关节镜肩部手术后的严重不良事件率与再手术:基于人群的队列研究
该研究基于英格兰NHS医院Episode Statistics及国家统计局死亡登记数据,纳入2009年4月1日至2017年3月31日期间261 248例患者共288 250例关节镜肩部手术,按肩峰下减压、肩袖修复、肩锁关节切除、盂肱稳定术和冻结肩松解分组。主要终点为术后90天内需住院治疗的严重不良事件(死亡、肺栓塞、肺炎、心肌梗死、急性肾损伤、卒中、尿路感染),次要终点为90天特定不良事件率及1年内再手术率(包括深部感染)。结果显示90天总体并发症率(含再手术)为1.2%(95%CI 1.2%–1.3%),肺炎最常见(0.3%),肺栓塞罕见(0.1%);1年再手术率3.8%,深部感染再手术率0.1%。作者认为常见肩关节镜手术的严重不良事件风险较低,但严重并发症确实存在。
要点
- 关节镜肩部手术后90天内严重不良事件(含再手术)总体发生率为1.2%(95%CI 1.2%–1.3%),每81例中1例。
- 90天不良事件率因手术类型而异:盂肱稳定术0.6%(0.5%–0.8%),冻结肩松解1.7%(1.5%–1.8%);校正年龄、合并症和性别后,未观察到手术类型的影响。
- 肺炎是最常见的严重不良事件(0.3%,95%CI 0.3%–0.4%),每303例中1例;肺栓塞罕见(0.1%,95%CI 0.1%–0.1%),每1428例中1例。
- 1年内再手术总体率为3.8%(95%CI 3.8%–3.9%),每26例中1例,范围从盂肱稳定术2.7%(2.5%–3.0%)到冻结肩松解5.7%(5.4%–6.1%)。
- 因深部感染再手术总体率为0.1%(95%CI 0.1%–0.1%),每1111例中1例,但肩袖修复后更高(0.2%,95%CI 0.2%–0.2%),每526例中1例。
适用人群与场景
- 2009年4月1日至2017年3月31日期间在英格兰NHS医院接受关节镜肩部手术、年龄≥16岁的患者,共261 248例患者、288 250例手术。
- 择期手术类型包括肩峰下减压、肩袖修复、肩锁关节切除、盂肱稳定术和冻结肩松解。
研究设计与关键结果
- 研究设计:基于人群的队列研究,使用英格兰NHS医院Episode Statistics及国家统计局死亡登记数据。
- 主要终点:术后90天内需住院治疗的严重不良事件(死亡、肺栓塞、肺炎、心肌梗死、急性肾损伤、卒中、尿路感染)。
- 90天总体并发症率(含再手术)为1.2%(95%CI 1.2%–1.3%),每81例中1例;按手术类型从盂肱稳定术0.6%(0.5%–0.8%)到冻结肩松解1.7%(1.5%–1.8%)。
- 校正年龄、合并症和性别后,未观察到手术类型对90天并发症率的影响。
- 肺炎最常见(0.3%,95%CI 0.3%–0.4%),每303例中1例;肺栓塞罕见(0.1%,95%CI 0.1%–0.1%),每1428例中1例。
- 1年再手术总体率3.8%(95%CI 3.8%–3.9%),每26例中1例,范围从盂肱稳定术2.7%(2.5%–3.0%)到冻结肩松解5.7%(5.4%–6.1%)。
- 因深部感染再手术总体率0.1%(95%CI 0.1%–0.1%),每1111例中1例;肩袖修复后为0.2%(95%CI 0.2%–0.2%),每526例中1例。
- 研究期间关节镜肩部手术数量增加,但肩峰下减压手术数量减少。
证据类型、等级与局限
- 证据类型:基于人群的队列研究。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,常见肩关节镜手术相关的严重不良事件风险较低。
- 作者指出,严重并发症确实会发生,包括1年内每26例患者中1例的再手术风险。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
OBJECTIVE: To provide clinicians and patients with accurate risk estimates of serious adverse events after common elective shoulder arthroscopic procedures, including reoperation within one year.
DESIGN: Population based cohort study.
SETTING: Hospital Episode Statistics for NHS England, including civil registration mortality data from the Office for National Statistics.
PARTICIPANTS: 288 250 arthroscopic shoulder procedures performed in 261 248 patients aged ≥16 years between 1 April 2009 and 31 March 2017. Elective procedures were grouped into subacromial decompression, rotator cuff repair, acromioclavicular joint excision, glenohumeral stabilisation, and frozen shoulder release.
MAIN OUTCOME MEASURES: The primary outcomes were rates of serious adverse events (mortality, pulmonary embolism, pneumonia, myocardial infarction, acute kidney injury, stroke, and urinary tract infection) requiring inpatient care within 90 days post-surgery. Secondary outcomes were specific adverse event rates at 90 days, and reoperations (including for deep infection) within one year.
RESULTS: The overall rate of complications within 90 days after arthroscopic shoulder surgery (including reoperation) was low at 1.2% (95% confidence interval 1.2% to 1.3%), with one in 81 patients at risk, and varied according to type of procedure, from 0.6% (0.5% to 0.8%) for glenohumeral stabilisation to 1.7% (1.5% to 1.8%) for frozen shoulder release. After adjustment for age, comorbidities, and sex, no effect of procedure type was observed. Pneumonia was the most common adverse event (0.3%, 0.3% to 0.4%), with one in 303 patients at risk. Pulmonary embolic events were rare, at 0.1% (0.1% to 0.1%), with one in 1428 patients at risk. At one year, the overall rate for reoperation was 3.8% (3.8% to 3.9%), with one in 26 patients at risk, ranging from 2.7% (2.5% to 3.0%) for glenohumeral stabilisation to 5.7% (5.4% to 6.1%) for frozen shoulder release. The overall rate of further surgery for deep infection was low, at 0.1% (0.1% to 0.1%), with one in 1111 patients at risk, but was higher after rotator cuff repair (0.2%, 0.2% to 0.2%), with one in 526 patients at risk. Over the study period the number of arthroscopic shoulder procedures increased, except for subacromial decompression, which decreased.
CONCLUSIONS: The findings of this study suggest that risks of serious adverse events associated with common shoulder arthroscopy procedures are low. Nevertheless, serious complications do occur, and include the risk of reoperation in one in 26 patients within one year.
STUDY REGISTRATION: Clinical.
TRIALS: gov NCT03573765.
参考来源
- Rees JL, Craig R, Nagra N, et al. Serious adverse event rates and reoperation after arthroscopic shoulder surgery: population based cohort study. BMJ. 2022. PMID: 35938625. doi:10.1136/bmj-2021-069901
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。